Business Wire

The IKEA Foundation Pledges More Than €11 Million in Emergency Humanitarian Aid for Sudan

Share

The IKEA Foundation has donated €5 million to Médecins Sans Frontières - Doctors Without Borders (MSF) to provide urgent medical care and supplies to people affected by the recent fighting in Sudan. It has also donated €6.7 million to Better Shelter to deploy 3,000 units to meet the immediate shelter needs of people displaced by the deadly conflict.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230608005375/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Illustration of fighting in Khartoum, Sudan Copyright: MSF/Atsuhiko Ochiai Countries: Sudan Date taken / Date Recorded: 04 May, 2023 Caption / Description: Aerial view captures the fighting and violence that erupted in Khartoum, Sudan. (Photo: Business Wire)

Intense fighting broke out in Khartoum, Sudan on 15 April and has since spread to other parts of the country. Local hospitals have been overwhelmed as people arrive with serious injuries caused by gunshots, explosions and airstrikes. The country’s health system, which has been struggling for decades, is facing a huge increase in needs and a shortage of supplies.

Within Sudan, many of those forced to flee are arriving in overcrowded urban areas already hosting internally displaced people. Sudan is also hosting more than one million refugees who have fled violence in neighbouring countries. This is placing immense strain on overstretched resources and exposing vulnerable people to risks such as evictions, family separation and gender-based violence.

Per Heggenes, CEO of the IKEA Foundation, said: “The violence in Sudan is a devastating human tragedy. It is our responsibility to alleviate the suffering of those caught in the crossfire. We strongly urge other funders to join us in delivering life-saving humanitarian assistance to Sudan. Let’s come together and make a tangible difference in the lives of those devastated by the conflict”

Urgent life-saving care by MSF

The IKEA Foundation’s donation will help MSF provide life-saving care both through medical interventions and by distributing supplies. It will also contribute to supporting MSF's activities across 10 states in Sudan. MSF teams have been treating war wounded, providing healthcare services and supplies, and water and sanitation.

Stephen Cornish – Director General – Médecins Sans Frontières (MSF) – Geneva Operational Centre said: “As the conflict in Sudan spirals into its second month and humanitarian needs outstrip response capacity, IKEA Foundation’s backing of our medical work across the country marks a collective resolution to take all possible measures to support those caught in the violence.

“The contribution is a testament to the determination and professionalism of our teams on the ground, who despite the many challenges and obstacles remain committed to extending life-saving healthcare. We are deeply thankful for the steadfast support of the IKEA Foundation. Today’s donation of €5 million will go a long way in helping us to provide humanitarian and medical aid to those most affected by the ongoing crisis.”

Immediate shelter needs by Better Shelter

An estimated 1.4 million Sudanese people have been displaced by this conflict already. This includes people fleeing internally and those crossing borders into neighbouring countries, including Chad and Ethiopia. Food, shelter, and protection services are among people’s urgent needs. To meet the immediate need for shelter as expressed by UNHCR, the UN Refugee Agency, Better Shelter will deploy 3,000 units immediately to neighbouring countries.

Johan Mast, Acting Manager Director, Better Shelter, said: “The current situation in Sudan is alarming. Millions of people are experiencing insecurity, food and water scarcity, and various challenges that require urgent attention. We are very grateful for the IKEA Foundation stepping in to assist and pleased to offer shelter to 15,000 individuals affected by the crisis. Shelter is a fundamental human need that provides physical protection and helps with emotional healing and recovery from the traumatic experiences they have endured.”

About the IKEA Foundation

The IKEA Foundation is a strategic philanthropy that focuses its grant making efforts on tackling the two biggest threats to children’s futures: poverty and climate change. It currently grants more than €200 million per year to help improve family incomes and quality of life while protecting the planet from climate change. Since 2009, the IKEA Foundation has granted more than €1.8 billion to create a better future for children and their families.

In 2021 the Board of the IKEA Foundation decided to make an additional €1 billion available over the next five years to accelerate the reduction of Greenhouse Gas emissions.

When an emergency strikes, time is of the essence. To provide the most efficient response, the IKEA Foundation provides extraordinary emergency funding to a select few partner organisations, who work mainly in Africa, Asia and the Middle East. In 2023 we have provided more than €31 Million in emergency funding.

About Médecins Sans Frontières

Médecins Sans Frontières (MSF) translates to Doctors without Borders, is a non-profit, self-governed, member-based organisation. MSF provides medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. MSF teams are made up of tens of thousands of health professionals, logistic and administrative staff. Their actions are guided by medical ethics and the principles of impartiality, independence and neutrality.

Since 1978, as a first-hand witness and responder to the dire needs of the Sudanese people, MSF has mobilised teams across 12 states, implemented around 20 projects from primary and secondary healthcare, mobile clinics, nutrition, reproductive and mental healthcare to vaccination, health promotion, and water and sanitation.

About Better Shelter

Better Shelter is a humanitarian non-profit organisation based in Sweden. It started developing temporary shelters more than ten years ago, with a big mission dedicated to sheltering displaced persons with safety, dignity and hope on their path towards a more stable life in a permanent home of their own. While its work has grown in scale, the small team continues to support partners and deliver shelters internationally from warehouses in Poland, Türkiye, and Panama.

Since 2015, Better Shelter has delivered more than 85,000 shelters to emergency, crisis, and development programs in over 80 countries. Better Shelter has impacted the lives of hundreds of thousands of displaced persons through collaborations with humanitarian NGOs and INGOs, UN bodies, philanthropic foundations, and academic institutions, including the UN Refugee Agency, UNHCR, the IKEA Foundation and the Aga Khan Agency for Habitat. www.bettershelter.org

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Lotika Mehta, lotika.mehta@ikeafoundation.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release

Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release

MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye